Tuesday, February 9, 2016

The Atlantic, GSK launch community health program at WHYY

The Atlantic magazine, with drugmaker GlaxoSmithKline as a sponsor, last week launched the first of several panel discussions that it is calling "A Conversation on Community Health."

The Atlantic, GSK launch community health program at WHYY

0 comments

The Atlantic magazine, with drugmaker GlaxoSmithKline as a sponsor, last week launched the first of several panel discussions that it is calling "A Conversation on Community Health."

The first panel and town hall meeting was held at WHYY in Philadelphia.

Philadelphia's Bill Cosby was the most famous panelist, but The Atlantic's Vice President Elizabeth Baker Keffer and GSK's North America Pharmaceuticals President Deirdre Connelly welcomed panelists and the audience.

Besides Cosby, the town hall speakers included Dr. Alvin Poussaint, professor of psychiatry at Harvard Medical School; Dr. Irwin Redlener, president and co-founder of the Children's Health Fund; Diane Cornman-Levy, executive director, Federation of Neighborhood Centers; Sarah Martinez-Helfman, executive director of the Eagles Youth Partnership; and Dr. Robert Simmons , director of the Master of Public Health Program at the Jefferson School of Population Health.

“In 2011, GSK set out to understand how we can work more effectively in the communities where we live and serve patients, and to answer the question: ‘What can GSK do to be a better health partner?’” Connelly said in a statement. “As we embark on a new era of healthcare in the United States, we have an opportunity to build upon the national momentum not only to expand access to healthcare, but to develop innovative approaches, uncover new ideas, and rethink incentives for improving the health of the community as a whole.”

A link to the reply of the video of the main event can be found here.

 

Staff Writer
0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com or 215-854-4506.

David Sell Staff Writer
Also on Philly.com:
letter icon Newsletter